This website uses cookies to improve the site and user experience. By continuing to browse this site,
you agree to accept our use of cookies. For more information, please review our Cookies Policy
SABCS 2021
Presentations
Tucatinib | Breast Cancer | Abstract #396
HER2CLIMB-04: Phase 2 trial of tucatinib + trastuzumab deruxtecan in patients with HER2+ locally advanced or metastatic breast cancer with and without brain metastases (trial in progress)
Tucatinib | Breast Cancer | Abstract #858
Updated results of tucatinib vs placebo added to trastuzumab and capecitabine for patients with previously treated HER2+ metastatic breast cancer with brain metastases (HER2CLIMB)
Tucatinib | Breast Cancer | Abstract #207
SGNTUC-019: Phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations: HER2-mutated breast cancer cohort (ongoing clinical trial)
Enfortumab Vedotin | Solid Tumors | Abstract #139
EV-202: Phase 2 Trial-in-Progress of Enfortumab Vedotin for Previously Treated Advanced Solid Tumors, Including Breast Cancer